BMY
33
-2
UAL
76
3
KHC
15
4
BLK
54
4
PFE
33
-2
COP
39
5
CNP
54
4
CMS
60
2
T
36
4
VLO
28
2
ETR
65
4
ITW
48
5
FLS
63
2
NFLX
74
4
TEL
60
2
EQR
37
3
ZION
52
3
NUE
41
2
UPS
53
3
CL
50
3
BMY
33
-2
UAL
76
3
KHC
15
4
BLK
54
4
PFE
33
-2
COP
39
5
CNP
54
4
CMS
60
2
T
36
4
VLO
28
2
ETR
65
4
ITW
48
5
FLS
63
2
NFLX
74
4
TEL
60
2
EQR
37
3
ZION
52
3
NUE
41
2
UPS
53
3
CL
50
3
Financhill
Back

Guardant Health 10K Form

Sell
48

GH
Guardant Health

Last Price:
$31.59
Seasonality Move:
10%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GH News And Ratings

See the #1 stock for the next 7 days that we like better than GH

GH Financial Statistics

Sales & Book Value

Annual Sales: $563.9M
Cash Flow: $-55.3M
Price / Cash Flow: 0
Annual Sales: $-0.49
Price / Book: 28.68

Profitability

EPS (TTM): -4.24000
Net Income (TTM): $-512.4M
Gross Margin: $336.9M
Return on Equity: -651%
Return on Assets: -30.37%

Guardant Health Earnings Forecast

Key Guardant Health Financial Ratios

  • The Gross Profit Margin over the past 8 years for GH is 59.74%.
  • The Selling, General & Administrative Expenses for GH have been equal to 79.98% of Gross Profit Margin.
  • The Research & Development expenses have been 65.11% of Revenue.
  • The Interest Expense is -0.54% of Operating Income.
  • The Net Earning history of GH is -85.02% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Guardant Health Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: GH
CUSIP: 40131M
Website: guardanthealth.com

Debt

Debt-to-Equity Ratio: -19
Current Ratio: 6.22
Quick Ratio: 5.51

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GH Technical Analysis vs Fundamental Analysis

Sell
48
Guardant Health (GH) is a Sell

Is Guardant Health a Buy or a Sell?

  • Guardant Health stock is rated a Sell
    The current Guardant Health [GH] share price is $31.57. The Score for GH is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.